Physician profile
Jonathan Somers
NPI 1376657643
$12,620.95
in general payments reported to CMS, 2019-2025
30 companies · $2,092 in 2025
The $2,092 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,531 · 2020: $483 · 2021: $2,211 · 2022: $1,739 · 2023: $1,875 · 2024: $2,690 · 2025: $2,092.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,656.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,699.63 | 2019-2024 | Xarelto, Opsumit, Uptravi |
| Amgen INC. | $1,611.74 | 2019-2025 | Repatha |
| Abbott Laboratories | $1,493.96 | 2019-2025 | Epic, Cardiomems, Navitor |
| Novo Nordisk INC | $1,464.70 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Medtronic, INC. | $1,059.69 | 2021-2025 | Corevalve Evolut R, Aurora Ev-Icd Mri Surescan, Linq II |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,054.82 | 2019-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $868.21 | 2019-2025 | |
| Edwards Lifesciences Corporation | $545.34 | 2021-2024 | Sapien 3 Ultra Resilia |
| E.R. Squibb & Sons, L.L.C. | $485.08 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals Lp | $470.45 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Medtronic Vascular, INC. | $248.59 | 2019-2020 | |
| Biostable Science & Engineering | $192.82 | 2022 | |
| Boston Scientific Corporation | $176.46 | 2022-2025 | Watchman Flx, Watchman Access System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $160.98 | 2021-2025 | Lifevest |
| Actelion Pharmaceuticals US, INC. | $156.34 | 2024-2025 | Opsumit, Uptravi |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $127.28 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $124.19 | 2024 | Arcalyst |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $113.68 | 2025 | |
| Amarin Pharma, INC. | $111.81 | 2019 | |
| Janssen Scientific Affairs, LLC | $102.62 | 2022 | |
| Merck Sharp & Dohme LLC | $69.91 | 2024-2025 | Verquvo |
| Lsi Solutions INC | $68.56 | 2024-2025 | Cor-Knot |
| Pfizer INC. | $59.73 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.38 | 2025 | |
| Abiomed | $30.32 | 2024 | Impella |
| Davol INC. | $25.85 | 2025 | Progel Applicator Spray Tips |
| Lilly USA, LLC | $20.19 | 2024 | Zepbound, Jardiance |
| Teleflex LLC | $18.48 | 2025 | Manta |
| Chiesi USA, INC. | $13.22 | 2023 | Kengreal, Cleviprex |
| Elutia, INC. | $9.92 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Somers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.